Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing drainage options after minimally invasive esophagectomy

Official title: Comparison of the Application Effects of Different Drainage Modes in the Perioperative Period of Minimally Invasive Three-Field Radical Esophagectomy for Esophageal Cancer

Run by Ruijin Hospital · NCT07004634 · Data updated 2026-11-12

This trial tests three different drainage approaches after minimally invasive esophagectomy to see which leads to less postoperative pain and fewer complications for adults with esophageal cancer.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment75 (estimated)
SponsorRuijin Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedApril 30, 2025
Main results expectedMay 1, 2026
Study endsAugust 1, 2026
Registry record updatedJune 10, 2025
Trial IDNCT07004634 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with pathologically confirmed esophageal cancer scheduled for three‑incision minimally invasive esophagectomy who are ASA class I–III and do not have chronic preoperative pain or major cardiopulmonary or coagulation contraindications are ideal candidates.

Probably not a fit

Patients with chronic pain or long‑term analgesic use, severe cardiopulmonary dysfunction (e.g., FEV1 <50%), coagulation disorders, need for reoperation, extensive pleural adhesions, or combined organ resections are excluded and therefore unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares three postoperative drainage strategies following three‑incision minimally invasive esophagectomy: a chest mediastinal tube, an abdominal mediastinal tube, and a combination of chest tube plus chest mediastinal tube. Adult patients (age ≥18) with pathologically confirmed esophageal cancer and ASA class I–III who are undergoing the specified procedure are eligible, while those with chronic pain, severe cardiopulmonary dysfunction, coagulation disorders, reoperation, or extensive intraoperative adhesions are excluded. The trial measures perioperative outcomes with emphasis on postoperative pain and complication profiles to address current evidence gaps. All procedures and follow-up occur at a single center (Ruijin Hospital, Shanghai).

Why it matters

Potential benefit: If successful, the results could identify a drainage approach that reduces postoperative pain and complications and guide standard practice after minimally invasive esophagectomy.

How similar studies have gone: Previous studies of mediastinal versus pleural drainage after esophagectomy have shown mixed results, and direct randomized comparisons of these three specific drainage strategies are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Pathologically confirmed esophageal cancer requiring three-incision esophagectomy (cervical, thoracic, and abdominal incisions)
* ASA physical status class I-III

Exclusion Criteria:

* History of chronic pain or long-term use of analgesics prior to surgery
* Severe cardiopulmonary dysfunction (e.g., FEV1 \<50%)
* Coagulation disorders or patients undergoing reoperation
* Intraoperative findings of extensive pleural adhesions, combined resection of adjacent organs, or other conditions deemed by the investigator to warrant exclusion

Where it's running

  • Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.